Multiple Sclerosis: Diagnostic and Treatment Frontiers
Multiple sclerosis (MS) — a disease of the central nervous system — causes damage to the myelin that protects axons in the brain, leading to inflammation and damage and thereby disrupting nerve impulses.
Given the widespread prevalence and the disabling effects of this neurological condition, it is critical that diagnostics and treatments for MS continue to improve. This one-day, translational conference will address these issues.
Plenary sessions will bring together academic and clinical researchers with industry leaders to discuss:
- Current therapeutics,
- Diagnostic, prognostic, and predictive biomarkers,
- MRI usage in diagnosis and monitoring, and
- Novel and emerging treatments